Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the “Research Group”). This study aims to evaluate the efficacy of Sona’s Targeted Hyperthermia Therapy (“THT”) technology in not only attenuating the development of colorectal, breast, and...
September 12, 2024